|
|
|
|
Preclinical Profile of the Pangenotypic HCV NS3/4A Protease Inhibitor GS-9857
|
|
|
Reported by Jules Levin
EASL 2015 April 22-26 Vienna Austria
James G. Taylor, Todd Appleby, Ona Barauskas, Xiaowu Chen, Hadas Dvory-Sobol, Ruoyu Gong, Johnny Lee, Elham Nejati, Brian E. Schultz, Yujin Wang, Chris Yang, Mei Yu, Sheila Zipfel, Katie Chan
Gilead Sciences, Inc., Foster City, California, USA
|
|
|
|
|
|
|